CANDIS WELCH: Open Payments
NPI 1720436603 · PANAMA CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,084 in 62 payments from 9 companies in 2025. Trend: 2023 $1,303 · 2024 $1,048 · 2025 $1,084
Food & beverage: $1,084
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 24 | $364 |
| AstraZeneca Pharmaceuticals LP | 14 | $280 |
| PFIZER INC. | 6 | $113 |
| GlaxoSmithKline, LLC. | 5 | $91 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $78 |
| Lilly USA, LLC | 3 | $55 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $50 |
| Exact Sciences Corporation | 2 | $35 |
| ABBVIE INC. | 1 | $19 |
Products named: Ozempic, FARXIGA, AIRSUPRA, TRELEGY ELLIPTA, Kerendia, PREVNAR 20, JARDIANCE, NURTEC ODT.
Industry payments across FL — which companies pay providers there.
